Richard Band

Richard Band

Richard Band is the author of Contrary Investing, in addition to numerous investment monographs. He has appeared on financial radio and TV and has been quoted in The Wall Street Journal, Business Week, Forbes and other leading publications. Richard graduated from Yale University, magna cum laude, and has been a respected investment commentator since 1982.

Recent Articles

Metlife Inc: MET’s Loss Is Our Gain

By Richard Band

Metlife (MET), the largest insurer in the U.S., may have been having a tough year, but the future is bright.

Procter & Gamble Co (PG): This Consumer Staples Titan Is Unstoppable

By Richard Band

Procter & Gamble (PG) stock isn't a stock that you should want to take off. It's a steady grower that will not disappoint over the long-term.

Wal-Mart Stores, Inc.: WMT Stock Beats the Retail Beating

By Richard Band

Big box retailers have been coming in with bad news, but Walmart stock has weathered the storm. Therefore, WMT is a bargain buy right now.

Microsoft Corporation: Don’t Worry, MSFT Still Has Long-Term Muscle

By Richard Band

Although MSFT has seen some turbulence lately, it's at a good price and there's a strong plan to back Microsoft stock up.

Is Apple Inc.’s (AAPL) Fall a Bad Thing?

By Richard Band

Apple (AAPL) stock may be down, but there are some things that suggest the worst may be over for Apple.

Exxon Mobil Corporation (XOM): There’s Only Darkness at the End of the Tunnel

By Richard Band

There's little doubt that Exxon Mobil (XOM) will be around another several decades, but its transformation from its current shape may well be underway.

United Technologies Corporation (UTX): Ignore Bumpy 2015, This Stock Is on the Rise

By Richard Band

United Technologies hit a few bumps in the road last year, but it has recovered: increasing popularity of its top-notch engine technology and the inevitable rise of military spending point to a high-flying 2016 for UTX stock.

Johnson & Johnson (JNJ): The Dividend King of Kings

By Richard Band

Reliable for more than 50 years, Johnson & Johnson is a dividend king. And given its recent Q1 earnings beat and increased guidance for the year, it's bound to stay on the throne for a long time.

Sanofi SA (ADR): SNY Pipeline Is Overflowing With Potential

By Richard Band

With 18 launches scheduled by 2020, Sanofi stock is bound to get a hit or two. And given its 3.8% dividend, SNY is also a safe growth pick.

Buckeye Partners, L.P. (BPL) Is One Energy MLP That’s Worth a Look

By Richard Band

Buckeye Partners (BPL) has seen the oil booms and busts play out time and again, which also means the company knows how to build a solid business that can weather any storm.

Load More